Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 13, 2010 00:01 ET | Source: Immune Pharmaceuticals Inc

EpiCept to Present at the Rodman & Renshaw Annual Global Investment Conference

EpiCept to Present at the Rodman & Renshaw Annual Global Investment Conference TARRYTOWN, N.Y.--(BUSINESS WIRE)--EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm Exchange: EPCT) today announced...
May 06, 2010 00:06 ET | Source: Immune Pharmaceuticals Inc

EpiCept Corporation Reports First Quarter 2010 Operating and Financial Results

EpiCept Corporation Reports First Quarter 2010 Operating and Financial Results Conference Call Begins at 9:00 a.m. Eastern Time Today TARRYTOWN, N.Y.--(BUSINESS WIRE)--Regulatory News: EpiCept...
May 04, 2010 00:03 ET | Source: Immune Pharmaceuticals Inc

EpiCept Earns $2 Million Milestone Payment from Meda AB

EpiCept Earns $2 Million Milestone Payment from Meda AB TARRYTOWN, N.Y.--(BUSINESS WIRE)-- Regulatory News: EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm Exchange: EPCT) today announced that...
May 03, 2010 20:03 ET | Source: Immune Pharmaceuticals Inc

EpiCept to Report First Quarter 2010 Operating and Financial Results on May 6, 2010

EpiCept to Report First Quarter 2010 Operating and Financial Results on May 6, 2010 TARRYTOWN, N.Y.--(BUSINESS WIRE)-- Regulatory News: EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm...
April 30, 2010 00:02 ET | Source: Immune Pharmaceuticals Inc

EpiCept to Present at the BIO International Convention

EpiCept to Present at the BIO International Convention TARRYTOWN, N.Y.--(BUSINESS WIRE)--EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm Exchange: EPCT) today announced that Jack Talley,...
April 23, 2010 00:11 ET | Source: Immune Pharmaceuticals Inc

Notice of the Annual Meeting of Stockholders of EpiCept Corporation

Notice of the Annual Meeting of Stockholders of EpiCept Corporation TARRYTOWN, N.Y.--(BUSINESS WIRE)--With this notice, stockholders of EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm Exchange:...
April 19, 2010 00:01 ET | Source: Immune Pharmaceuticals Inc

EpiCept Announces Commercial Launch of Ceplene® in the United Kingdom

EpiCept Announces Commercial Launch of Ceplene® in the United Kingdom TARRYTOWN, N.Y.--(BUSINESS WIRE)--EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm Exchange: EPCT) today announced that the...
March 02, 2010 18:05 ET | Source: Immune Pharmaceuticals Inc

EpiCept to Present at 30th Annual Cowen and Company Health Care Conference

EpiCept to Present at 30th Annual Cowen and Company Health Care Conference TARRYTOWN, N.Y.--(BUSINESS WIRE)--Regulatory News: EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm: EPCT) announced...
February 25, 2010 00:01 ET | Source: Immune Pharmaceuticals Inc

EpiCept Reports Fourth Quarter Financial Results, Provides Business Update

EpiCept Reports Fourth Quarter Financial Results, Provides Business Update TARRYTOWN, N.Y.--(BUSINESS WIRE)-- EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm Exchange: EPCT) today announced...
February 23, 2010 00:02 ET | Source: Immune Pharmaceuticals Inc

EpiCept Adopts Amendment to Company By-Laws

EpiCept Adopts Amendment to Company By-Laws TARRYTOWN, N.Y.--(BUSINESS WIRE)--EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm: EPCT) announced today that on February 11, 2010, the Board...